Abstract
In this paper, we formulate a special epidemic dynamic model to describe the transmission of COVID-19 in Algeria. We derive the threshold parameter control reproduction number 
, and present the effective control reproduction number (Rc(t)) as a real-time index for evaluating the epidemic under different control strategies. Due to the limitation of the reported data, we redefine the number of accumulative confirmed cases with diagnostic shadow and then use the processed data to do the optimal numerical simulations. According to the control measures, we divide the whole research period into six stages. And then the corresponding medical resource estimations and the average effective control reproduction numbers for each stage are given. Meanwhile, we use the parameter values which are obtained from the optimal numerical simulations to forecast the whole epidemic tendency under different control strategies.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was partially supported by National Natural Science Foundation of China(Grant Nos. 41704116, 11901234), Jilin Provincial Excellent Youth Talents Foundation(Grant No. 20180520093JH), Scientific Research Project of Education Department of Jilin Province (Grant No. JJKH20200933KJ), Fundamental Research Funds for the Central Universities, JLU (Grant No. 93K172020K27).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The National Health Commission of the People's Republic of China has determined that data collection and analysis of cases and close contacts are part of ongoing investigations into public health outbreaks and are therefore exempt from the approval requirements of the agency review committee.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Email addresses: jiajiwei{at}jlu.edu.cn (J. Jia), ywliu{at}jlu.edu.cn (Y. Liu), shanrt19{at}mails.jlu.edu.cn (R. Shan), khaledzennir4{at}gmail.com (K. Zennir), zhangran{at}jlu.edu.cn (R. Zhang)
Data Availability
The data used in this study are all public data. Contact the author if necessary.
